ReviewNanomaterials (Basel, Switzerland)2025
Forest Tree and Woody Plant-Based Biosynthesis of Nanoparticles and Their Applications.
Review in Nanomaterials (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Are Silver and Gold Nanoparticles Obtained by 'Green' Synthesis Biocompatible?Nanomaterials (Basel, Switzerland) · 2026Review
- Potential Sustainability and Stress Resilience of Forest Trees Induced by Nanotechnology Applications.Plant-environment interactions (Hoboken, N.J.) · 2025Review
- Correction: Siam et al. Forest Tree and Woody Plant-Based Biosynthesis of Nanoparticles and Their Applications.Nanomaterials (Basel, Switzerland) · 2025Article
Corrections and comments
- Erratum issued
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Forest ecosystems represent a natural repository of biodiversity, bioenergy, food, timber, water, medicine, wildlife shelter, and pollution control. In many countries, forests offer great potential to provide biogenic resources that could be utilized for large-scale biotechnological synthesis and products. The evolving nanotechnology could be an excellent platform for the transformation of forest products into value-added nanoparticles (NPs). It also serves as a tool for commercial production, placing the forest at the heart of conservation and sustainable management strategies. NPs are groups of atoms with a size ranging from 1 to 100 nm. This review analyzes the scholarly articles published over the last 25 years on the forest and woody plant-based green synthesis of NPs, highlighting the plant parts and applications discussed. The biosynthesis of nanomaterials from plant extracts provides inexpensiveness, biocompatibility, biodegradability, and environmental nontoxicity to the resultant NPs. The leaf is the most critical organ in woody plants, and it is widely used in NP biosynthesis, perhaps due to its central functions of bioactive metabolite production and storage. Most biosynthesized NPs from tree species have been used and tested for medical applications. For sustainable advancements in forest-based nanotechnology, broader species coverage, expanded applications, and interdisciplinary collaboration are essential.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.